Kenneth S. Boger

2010

In 2010, Kenneth S. Boger earned a total compensation of $2.6M as Senior Vice President and Chief Legal Officer at Vertex Pharmaceuticals, a 18% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$342,563
Option Awards$1,420,310
Salary$435,175
Stock Awards$396,881
Other$12,338
Total$2,607,267

Boger received $1.4M in option awards, accounting for 54% of the total pay in 2010.

Boger also received $342.6K in non-equity incentive plan, $435.2K in salary, $396.9K in stock awards and $12.3K in other compensation.

Rankings

In 2010, Kenneth S. Boger's compensation ranked 2,332nd out of 10,439 executives tracked by ExecPay. In other words, Boger earned more than 77.7% of executives.

ClassificationRankingPercentile
All
2,332
out of 10,439
78th
Division
Manufacturing
807
out of 3,838
79th
Major group
Chemicals And Allied Products
163
out of 926
82nd
Industry group
Drugs
85
out of 685
88th
Industry
Pharmaceutical Preparations
67
out of 481
86th
Source: SEC filing on April 8, 2011.

Boger's colleagues

We found five more compensation records of executives who worked with Kenneth S. Boger at Vertex Pharmaceuticals in 2010.

2010

Matthew Emmens

Vertex Pharmaceuticals

Chief Executive Officer

2010

Peter Mueller

Vertex Pharmaceuticals

Chief Scientific Officer

2010

Ian Smith

Vertex Pharmaceuticals

Chief Financial Officer

2010

Amit Sachdev

Vertex Pharmaceuticals

Senior Vice President, Corporate Affairs and Public Policy, and Commercial Business Lead, Canada

2010

Nancy Wysenski

Vertex Pharmaceuticals

EVP & Chief Commercial Officer

In-depth

You may also like